Abstract
Half of the group of 24 showed temporary changes. These changes were maximal at the peak doses, either in the direction of decreased depression and withdrawal (8 cases) or increased restlessness and tension (4 cases). These changes were not lasting, and as the medication was decreased, the group as a whole returned to its original level. The temporary periods of improvement occurred in a peculiar cyclic pattern, lasting from a few days to a few weeks at a time. In higher doses the drug was accompanied by changes in the mood and activity of chronic schizophrenic patients, but did not bring about a lasting or dependable improvement in psychiatric status or hospital adjustment. The use of liothyronine in psychiatric disorders must still be considered in experimental stage.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
